Clinical Trial Update: Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients [Phase 2]

View source ↗

Summary

Phase II trial evaluating the tolerability and efficacy of bosutinib in patients with chronic myeloid leukemia in the chronic phase.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Bosutinib (bosutinib)

Snippet

Sponsor: University of Bonn | Conditions: Chronic Myelogenous Leukaemia | Phase 2 | Status: UNKNOWN